Chemical Compound

(S)-N-Acetyl-L-leucyl-N-(1-formylpentyl)-L-leucinamide; ALLN; ALLnL; CI-1 (peptide); Calp I; Calpain inhibitor I; MG 101; (S)-N-Acetyl-L-leucinyl-L-leucinyl-L-norleucinal

CAS Registry Number 110044-82-1
返回搜索 申请报价
(S)-N-Acetyl-L-leucyl-N-(1-formylpentyl)-L-leucinamide; ALLN; ALLnL; CI-1 (peptide); Calp I; Calpain inhibitor I; MG 101; (S)-N-Acetyl-L-leucinyl-L-leucinyl-L-norleucinal 结构式
Primary record

(S)-N-Acetyl-L-leucyl-N-(1-formylpentyl)-L-leucinamide; ALLN; ALLnL; CI-1 (peptide); Calp I; Calpain inhibitor I; MG 101; (S)-N-Acetyl-L-leucinyl-L-leucinyl-L-norleucinal

库存
2,270 克
纯度
99.1 %
CAS
110044-82-1

化合物标识与属性

CAS
110044-82-1
PubChem CID
443118
SMILES
CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)C
Canonical SMILES
CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O

名称与同义词

  • Calpain inhibitor I
  • Allnal
  • ALLN
  • Acetylleucyl-leucyl-norleucinal
  • MG-101
  • Ac-Leu-leu-nle-al
  • 110044-82-1
  • Calpain inhibitor-1
  • LLnL peptide
  • ALLN peptide
  • N-Ac-Leu-leu-norleucinal
  • AcLLNal
  • LLNL
  • Calp I
  • N-acetylleucylleucylnorleucinal
  • ALLnL
  • CI-1[peptide]
  • Ac-LL-Nle-aldehyde
  • Ac-Leu-Leu-Nle-H
  • Calpain Inhibitor I, ALLN
  • CALPAIN IHIBITOR I
  • Cpi(1)
  • Ac-Leu-Leu-Nle-CHO
  • Ac-Leu-Leu-Nle-aldehyde
  • RefChem:552506
  • Ac-Leu-Leu-L-norleucinal
  • N-Acetyl-leucyl-leucyl-norleucinal
  • UPCMLD-DP120
  • AC1L9E1Z
  • CHEBI:2423
  • CHEMBL304784
  • acetyl-leucyl-leucyl-norleucinal
  • N-Acetyl-Leu-Leu-Nle-CHO
  • N-acetyl-Leu-Leu-norLeu-al
  • Ac-L-Leu-L-Leu-norleucinal
  • BSPBio_001559
  • KBioGR_000279
  • KBioSS_000279
  • MG-101 (ALLN)
  • N-Acetyl-Leu-Leu-norleucinal
  • SCHEMBL231491
  • Ac-Leu-Leu-Nle-CHO; ALLN
  • acetyl-leucyl-leucyl-norleucine-aldehyde
  • FMYKJLXRRQTBOR-BZSNNMDCSA-N
  • MFCD00065505
  • Ac-Leu-Leu-Nle-H (Aldehyde)
  • C20H37N3O4
  • MG101
  • orb1300637
  • n-acetylleucyl-leucyl-norleucinal
  • SCHEMBL15539031
  • UPCMLD-DP120:001
  • UPCMLD-DP120:002
  • BCBcMAP01_000098
  • GTPL13381
  • IAL-3671-PI
  • KBio2_000279
  • KBio2_002847
  • KBio2_005415
  • KBio3_000557
  • KBio3_000558
  • DTXSID70911457
  • Bio2_000279
  • Bio2_000759
  • HMS1361N21
  • HMS1791N21
  • HMS1989N21
  • HMS3402N21
  • acetyl-leucinyl-leucinyl-norleucinal
  • EX-A3085
  • ZINC3826241
  • Calpain inhibitor I;Ac-LLnL-CHO;ALLN
  • 2300AH
  • BDBM50069792
  • CID443118
  • MG 101
  • s7386
  • AKOS024457579
  • C20-H37-N3-O4
  • CCG-208037
  • CS-4961
  • DB07558
  • N-acetyl-L-leucyl-L-leucyl-L-leucinal
  • Ac-Leu-Leu-[(S)-1-Formylpentyl]NH2
  • IDI1_034029
  • (2S)-2-[(Ac-Leu-Leu-)Amino]hexanal
  • n-acetyl-l-leucinyl-l-leucinyl-l-norleucinal
  • NCGC00161662-01
  • NCGC00161662-02
  • NCGC00161662-03
  • NCGC00161662-08
  • (S)-2-(Ac-L-Leu-L-Leu-)Aminohexanal
  • BS-48888
  • Calpain Inhibitor I, >=97.0% (TLC)
  • HY-18964
  • N-Acetyl-L-leucyl-L-leucyl-L-norleucinal
  • (S)-2-[(Ac-L-Leu-L-Leu-)Amino]hexanal
  • J675.054K
  • N-Acetyl-L-leucine-L-leucine-L-norleucinal
  • A2602
  • Ac-L-Leu-L-Leu-[(S)-1-Formylpentyl]NH2
  • ALLN - CAS 110044-82-1
  • InSolution ALLN - CAS 110044-82-1
  • NS00069341
  • (2S)-2-[(Ac-L-Leu-L-Leu-)Amino]hexanal
  • (2S)-2-[(N-Acetyl-Leu-Leu-)amino]hexanal
  • (S)-2-(N-Acetyl-L-Leu-L-Leu-)aminohexanal
  • (S)-2-[(N-Ac-L-Leu-L-Leu-)Amino]hexanal
  • Calpain Inhibitor I, >=97% (TLC), powder
  • C11306
  • E78366
  • A906400
  • N-Acetyl-L-Leu-L-Leu-[(S)-1-formylpentyl]NH2
  • (S)-2-acetamido-N-((S)-1-amino-4-methyl-1-oxopentan-2-yl)-4-methyl-N-((S)-1-oxohexan-2-yl)pentanamide
  • BRD-K35923252-001-01-0
  • N-{N-[N-Acetyl-(S)-leucyl]-(S)-leucyl}norleucinal
  • Q27096777
  • (2S)-2-acetamido-4-methyl-N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxohexan-2-yl]amino]pentan-2-yl]pentanamide
  • (S)-N-Acetyl-L-leucyl-N-(1-formylpentyl)-L-leucinamide
  • (2S)-2-[(2S)-2-acetamido-4-methylpentanamido]-N-[(1S)-1-formylpentyl]-4-methylpentanamide
  • N-Acetyl-L-leucyl-N-((1S)-1-formylpentyl)-L-leucinamide
  • N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-L-leucinamide
  • N-acetyl-L-leucyl-N-[(2S)-1-oxohexan-2-yl]-L-leucinamide
  • 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE
  • Calpain Inhibitor I, N-Acetyl-Leu-Leu-norleucinal, synthetic
  • L-Leucinamide, N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-
  • N-[N-(N-Acetyl-L-leucyl)-L-leucyl]-L-norleucine, aldehyde deriv.
  • Nalpha-(N-Acetyl-L-leucyl)-N-[(1S)-1-formylpentyl]-L-leucinamide
  • (2S)-2-[(2S)-2-ACETAMIDO-4-METHYLPENTANAMIDO]-4-METHYL-N-[(2S)-1-OXOHEXAN-2-YL]PENTANAMIDE
  • (2S)-2-((2S)-2-acetamido-4-methylpentanamido)-N-((1S)-1-formylpentyl)-4-methylpentanamide
  • (2S)-2-[(1-Hydroxyethylidene)amino]-N-[(2S)-1-hydroxy-4-methyl-1-{[(2S)-1-oxohexan-2-yl]imino}pentan-2-yl]-4-methylpentanimidic acid
  • (S)-N-Acetyl-L-leucyl-N-(1-formylpentyl)-L-leucinamide; ALLN; ALLnL; CI-1 (peptide); Calp I; Calpain inhibitor I; MG 101; (S)-N-Acetyl-L-leucinyl-L-leucinyl-L-norleucinal
  • 2-[(1-Hydroxyethylidene)amino]-N-{1-hydroxy-4-methyl-1-[(1-oxohexan-2-yl)imino]pentan-2-yl}-4-methylpentanimidic acid
  • ALLN Ac-LLnL-CHO MG-101 N-Acetyl-Leu-Leu-Norleu-al N-Acetyl-L-leucyl-L-leucyl-L-norleucinal
  • ALLN, Ac-LLnL-CHO, MG-101, N-Acetyl-Leu-Leu-Norleu-al, N-Acetyl-L-leucyl-L-leucyl-L-norleucinal
  • CIB